Chandra Mohan Reddy Muthumula Source Confirmed

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Researcher

National Center for Toxicological Research

faculty

4 h-index 13 pubs 73 cited

Research Areas

Nanoparticle-Based Drug Delivery Cancer Treatment and Pharmacology Pharmacological Effects and Toxicity Studies Gut microbiota and health Maternal and Perinatal Health Interventions Drug Transport and Resistance Mechanisms Cancer-related molecular mechanisms research

Links

ORCID

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

Chandra Mohan Reddy Muthumula's research investigates the development and evaluation of novel drug formulations, with a particular focus on nanotechnology and its application in cancer treatment and overcoming physiological barriers. His work includes the creation of pH-sensitive liposome formulations for targeted delivery of chemotherapeutic agents, such as a peptidomimetic-Dox conjugate for HER2-positive cancers. Muthumula also explores strategies for enhancing nanocrystal formulations through excipient selection to improve administration routes. His research extends to the impact of in utero and lactational exposure to antiretroviral therapy on offspring, examining gut microbial composition and metabolic function. Additionally, he has evaluated gender differences in the pharmacokinetics of specific drug formulations in rat models and studied the safety and translational aspects of compounds like Pseurotin A for prostate cancer recurrence suppression. Muthumula has published 13 papers, with an h-index of 4 and 73 citations, and remains an active researcher.

Metrics

  • h-index: 4
  • Publications: 13
  • Citations: 73

Selected Publications

  • Gestational exposure to HIV drugs alters intestinal mucosa-associated microbial diversity in adult rat offspring (2025) DOI
  • Effect of in utero and lactational exposure to antiretroviral therapy on the gut microbial composition and metabolic function in aged rat offspring (2025) DOI
  • Strategies to Enhance Nanocrystal Formulations for Overcoming Physiological Barriers Across Diverse Routes of Administration (2025) DOI
  • Evaluation of gender differences in the pharmacokinetics of oral zileuton nanocrystalline formulation using a rat model (2024) DOI

Similar Researchers

Based on overlapping research topics

Brandon S.B. Canup National Center for Toxicological Research
Nanoparticle-Based Drug Delivery Cancer Treatment and Pharmacology Pharmacological Effects and Toxicity Studies
Good match 4 shared topics
Taylor H. McElroy University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology Pharmacological Effects and Toxicity Studies Gut microbiota and health
Good match 3 shared topics
Yusra B. Medik University of Arkansas for Medical Sciences
Nanoparticle-Based Drug Delivery Cancer Treatment and Pharmacology Pharmacological Effects and Toxicity Studies
Good match 4 shared topics
Fengping Lv University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology Pharmacological Effects and Toxicity Studies Drug Transport and Resistance Mechanisms
Good match 4 shared topics
Peter A. Crooks University of Arkansas for Medical Sciences
Nanoparticle-Based Drug Delivery Cancer Treatment and Pharmacology Drug Transport and Resistance Mechanisms
Good match 4 shared topics
Alexia S. Terry University of Arkansas for Medical Sciences
Cancer Treatment and Pharmacology Gut microbiota and health Cancer-related molecular mechanisms research
Good match 3 shared topics